A high-throughput chemical screen with FDA approved drugs reveals that the antihypertensive drug Spironolactone impairs cancer cell survival by inhibiting homology directed repair
Or David Shahar, Alkmini Kalousi, Lital Eini, Benoit Fisher, Amelie Weiss, Jonatan Darr, Olga Mazina, Shay Bramson, Martin Kupiec, Amir Eden, Eran Meshorer, Alexander V. Mazin, Laurent Brino, Michal Goldberg*, Evi Soutoglou
Research output: Contribution to journal › Article › peer-review
37Scopus
citations
Fingerprint
Dive into the research topics of 'A high-throughput chemical screen with FDA approved drugs reveals that the antihypertensive drug Spironolactone impairs cancer cell survival by inhibiting homology directed repair'. Together they form a unique fingerprint.